Golden Valley Development, Inc (GVDI)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -141.81 Thousand USD | -28.92% |
| 2022 | -110 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | -3.27 Million USD | -954.17% |
| 2014 | -310.7 Thousand USD | -5078.33% |
| 2013 | -6000.00 USD | 0.0% |
| 2011 | -73.89 Thousand USD | -9.34% |
| 2010 | -67.58 Thousand USD | 62.78% |
| 2009 | -181.56 Thousand USD | -673.99% |
| 2008 | -23.45 Thousand USD | 3.93% |
| 2007 | -24.41 Thousand USD | -10.48% |
| 2006 | -22.1 Thousand USD | -60.09% |
| 2005 | -13.8 Thousand USD | -291.74% |
| 2004 | 7200.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -35.79 Thousand USD | 2.99% |
| 2024 Q1 | -36.9 Thousand USD | -4.98% |
| 2023 Q4 | -35.15 Thousand USD | 4.09% |
| 2023 FY | -141.81 Thousand USD | -28.92% |
| 2023 Q1 | -35.75 Thousand USD | 0.0% |
| 2023 Q2 | -34.25 Thousand USD | 4.2% |
| 2023 Q3 | -36.65 Thousand USD | -7.01% |
| 2022 FY | -110 Thousand USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2016 Q1 | -1.67 Million USD | 50.58% |
| 2015 Q1 | -97.82 Thousand USD | 89.68% |
| 2015 Q3 | -4460.00 USD | 99.79% |
| 2015 Q4 | -3.37 Million USD | -75667.49% |
| 2015 FY | -3.27 Million USD | -954.17% |
| 2015 Q2 | -2.08 Million USD | -2030.4% |
| 2014 FY | -310.7 Thousand USD | -5078.33% |
| 2014 Q4 | -947.73 Thousand USD | 0.0% |
| 2013 FY | -6000.00 USD | 0.0% |
| 2011 FY | -73.89 Thousand USD | -9.34% |
| 2010 Q1 | -1843.00 USD | 98.88% |
| 2010 FY | -67.58 Thousand USD | 62.78% |
| 2010 Q2 | -1843.00 USD | 0.0% |
| 2009 Q1 | -5284.00 USD | -53.65% |
| 2009 Q4 | -164.22 Thousand USD | -3053.89% |
| 2009 FY | -181.56 Thousand USD | -673.99% |
| 2009 Q3 | -5207.00 USD | 31.93% |
| 2009 Q2 | -7649.00 USD | -44.76% |
| 2008 FY | -23.45 Thousand USD | 3.93% |
| 2008 Q4 | -3439.00 USD | 50.68% |
| 2008 Q3 | -6973.00 USD | -104.73% |
| 2008 Q2 | -3406.00 USD | 70.59% |
| 2008 Q1 | -11.58 Thousand USD | 44.37% |
| 2007 Q2 | 177.00 USD | 112.81% |
| 2007 Q1 | -1382.00 USD | 47.11% |
| 2007 Q3 | -2413.00 USD | -1463.28% |
| 2007 Q4 | -20.81 Thousand USD | -762.74% |
| 2007 FY | -24.41 Thousand USD | -10.48% |
| 2006 Q4 | -2613.00 USD | 24.22% |
| 2006 Q2 | -1597.00 USD | 81.76% |
| 2006 Q1 | -8757.00 USD | -399.83% |
| 2006 Q3 | -3448.00 USD | -115.9% |
| 2006 FY | -22.1 Thousand USD | -60.09% |
| 2005 FY | -13.8 Thousand USD | -291.74% |
| 2005 Q3 | -5234.00 USD | 28.12% |
| 2005 Q4 | -1752.00 USD | 66.53% |
| 2005 Q2 | -7282.00 USD | 0.0% |
| 2004 FY | 7200.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 112.181% |
| Ansell Limited | 129.3 Million USD | 100.11% |
| Ansell Limited | 129.3 Million USD | 100.11% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 100.455% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 91.113% |
| Psykey, Inc. | -797.5 Thousand USD | 82.218% |
| ConvaTec Group Plc | 262.7 Million USD | 100.054% |
| ConvaTec Group Plc | 262.7 Million USD | 100.054% |
| Encision Inc. | -640.78 Thousand USD | 77.869% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -29.0% |
| Innovative MedTech Inc. | -4.27 Million USD | 96.682% |
| LifePoint, Inc. | -7.49 Million USD | 98.108% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 97.812% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 142.973% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -15.396% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 69.652% |
| SmileDirectClub, Inc. | -241.15 Million USD | 99.941% |
| Sector 10, Inc. | -39.84 Thousand USD | -255.913% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.044% |
| SheerVision, Inc. | 155.72 Thousand USD | 191.064% |
| United Health Products, Inc. | -2.42 Million USD | 94.156% |
| Vasamed, Inc. | 4.74 Million USD | 102.99% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 93.819% |
| Yubo International Biotech Limited | -1.2 Million USD | 88.234% |